| Literature DB >> 11114393 |
O Kayser1, A F Kiderlen, H Laatsch, S L Croft.
Abstract
A series of monomeric and dimeric naphthoquinones with potential for treatment of Leishmania infections was identified in vitro using both a direct cytotoxicity assay against extracellular promastigotes of Leishmania donovani, L. infantum, L. enriettii, and L. major and a test against intracellular amastigote L. donovani residing within murine macrophages. Several naphthoquinones proved to be active at concentrations in the microgram range (EC(50) 0.9-17.0 microg/ml). When tested against a panel of human cancer cell lines (KB, SKMel, A549, MDA) and murine bone marrow culture-derived macrophages (BMMPhi) as mammalian host cell controls, compounds with anti-Leishmania-activity showed moderate (EC(50)>25 microg/ml) to pronounced (EC(50)<10 microg/ml) toxic effects.Entities:
Mesh:
Substances:
Year: 2000 PMID: 11114393 DOI: 10.1016/s0001-706x(00)00161-3
Source DB: PubMed Journal: Acta Trop ISSN: 0001-706X Impact factor: 3.112